GenapSys is headquartered in Redwood City California. With extensive experience in the DNA sequencing market, GenapSys has created an affordable benchtop NGS sequencer, without compromising on accuracy.
The GenapSys Sequencer is the leader in the new generation of sequencing enabling affordable sequencing with scalable capacity from your own lab bench, without compromising on accuracy. Based on a proprietary NGS technology with proven sequencing-by-synthesis chemistry and utilising electrical-based detection of single nucleotide incorporations, sequencing is carried out on microfluidic chips (CMOS chips) that have a scalable number of detectors for applications ranging right from targeted sequencing of specific amplicons to genome-scale data collection.
Cambridge Bioscience exclusively provide the GenapSys Sequencer, GenapSys Sequencing Prep System and GenapSys products in the UK and Ireland.